HealthEquity, Inc. (NASDAQ:HQY) Stock Holdings Lowered by Wasatch Advisors LP

Wasatch Advisors LP trimmed its position in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 3.2% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 7,513,745 shares of the company's stock after selling 245,145 shares during the quarter. HealthEquity makes up approximately 3.6% of Wasatch Advisors LP's investment portfolio, making the stock its 2nd largest position. Wasatch Advisors LP owned about 8.67% of HealthEquity worth $720,944,000 at the end of the most recent quarter.

A number of other large investors have also modified their holdings of the business. Barclays PLC increased its holdings in shares of HealthEquity by 209.3% during the 3rd quarter. Barclays PLC now owns 166,492 shares of the company's stock worth $13,628,000 after buying an additional 112,667 shares during the last quarter. Sanctuary Advisors LLC acquired a new position in shares of HealthEquity in the third quarter worth $260,000. Wilmington Savings Fund Society FSB purchased a new stake in HealthEquity during the 3rd quarter worth about $150,000. Franklin Resources Inc. lifted its stake in HealthEquity by 0.7% in the third quarter. Franklin Resources Inc. now owns 1,640,215 shares of the company's stock worth $139,369,000 after acquiring an additional 11,659 shares during the last quarter. Finally, GAMMA Investing LLC lifted its position in shares of HealthEquity by 32.9% during the 4th quarter. GAMMA Investing LLC now owns 1,248 shares of the company's stock worth $120,000 after purchasing an additional 309 shares during the last quarter. Hedge funds and other institutional investors own 99.55% of the company's stock.

Insider Activity

In related news, EVP Michael Henry Fiore sold 8,881 shares of HealthEquity stock in a transaction dated Friday, April 4th. The stock was sold at an average price of $78.26, for a total transaction of $695,027.06. Following the completion of the sale, the executive vice president now owns 56,655 shares in the company, valued at approximately $4,433,820.30. This trade represents a 13.55 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Robert W. Selander sold 5,750 shares of HealthEquity stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $111.29, for a total transaction of $639,917.50. Following the completion of the sale, the director now directly owns 78,219 shares of the company's stock, valued at $8,704,992.51. The trade was a 6.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 20,381 shares of company stock valued at $1,781,432 in the last three months. 2.20% of the stock is currently owned by company insiders.

HealthEquity Stock Performance

Shares of HealthEquity stock traded up $2.03 on Friday, reaching $84.52. 944,006 shares of the stock were exchanged, compared to its average volume of 765,335. The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.51. The firm has a market capitalization of $7.31 billion, a PE ratio of 77.54, a PEG ratio of 1.60 and a beta of 0.49. HealthEquity, Inc. has a 1-year low of $65.01 and a 1-year high of $115.59. The business has a fifty day moving average price of $94.78 and a two-hundred day moving average price of $96.30.

Analysts Set New Price Targets

Several brokerages have recently weighed in on HQY. KeyCorp cut their target price on HealthEquity from $110.00 to $100.00 and set an "overweight" rating on the stock in a research report on Wednesday. The Goldman Sachs Group reduced their target price on HealthEquity from $107.00 to $94.00 and set a "neutral" rating for the company in a report on Thursday, March 27th. Raymond James upgraded HealthEquity from an "outperform" rating to a "strong-buy" rating and dropped their price target for the stock from $120.00 to $115.00 in a research note on Tuesday, March 25th. Barrington Research reiterated an "outperform" rating and issued a $112.00 price objective on shares of HealthEquity in a research note on Friday, April 11th. Finally, Wells Fargo & Company raised their target price on shares of HealthEquity from $110.00 to $125.00 and gave the stock an "overweight" rating in a research report on Wednesday, February 26th. One analyst has rated the stock with a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat, the company has an average rating of "Buy" and a consensus price target of $111.75.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.